Biomarker research on the association between the effect and the HPV infection on the multimodal therapy for oropharyngeal squamous cell carcinoma

Biomarker research on the association between the effect and the HPV infection on the multimodal therapy for oropharyngeal squamous cell carcinoma - Biomarker research on the HPV infection for oropharyngeal carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021572

Enrollment

213

Registered

2016-03-23

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal squamous cell carcinoma

Interventions

chemotherapy, chemoradiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: oropharyngeal squamous cell carcinoma Stage III/IV PS 0,1 No prior treatment

Exclusion criteria

Exclusion criteria: Patient with surgical treatment Distant metastasis Double cancer

Design outcomes

Primary

Measure	Time frame
The efficacy of multimodal therapy and HPV infection for oropharyngeal carcinoma	—

Countries

Japan

Contacts

Public ContactKatsunari Yane

Kindai University Nara Hospital Otorhinolaryngology

kyane@med.kindai.ac.jp0743-77-0880

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026